Citation Impact
Citing Papers
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
2013
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
Distinct fibroblast lineages determine dermal architecture in skin development and repair
2013 StandoutNature
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
2019
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192
2006
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
2011
Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects
2014
Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial
2010
Idiopathic pulmonary fibrosis
2017 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease
2011
Sjögren's syndrome
2005 Standout
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
2014
Why Most Published Research Findings Are False
2005 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The assessment of the patient with systemic sclerosis
2003
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Drug penetration in solid tumours
2006 Standout
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
2011
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
2002
Cancer Metastasis: Building a Framework
2006 Standout
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients
2013
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2015
Mechanisms and consequences of fibrosis in systemic sclerosis
2006
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry
2015
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
2014
The biology and function of fibroblasts in cancer
2016 Standout
Relaxin: a pregnancy hormone as central player of body fluid and circulation homeostasis
2003
Systemic sclerosis
2017 Standout
Psoriasis
2021 Standout
Rheumatoid Arthritis
1990
Correlation of serum anti‐DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis
2003
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
2005 StandoutNobel
Scleroderma renal crisis: patient characteristics and long-term outcomes
2007
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model
2007
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
2010
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma
2001
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre
2010
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma
2004
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
2013
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)
2011
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Peptide‐containing nerves in labial salivary glands in sjögren's syndrome
1992
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Inhibition of markers of hepatic stellate cell activation by the hormone relaxin
2003
Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis
2014
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts
2007 StandoutNobel
Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study
2018
Atherosclerosis — An Inflammatory Disease
1999 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Microenvironmental regulation of metastasis
2008 Standout
Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin
2004 StandoutNobel
Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases
2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
2010
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Genetics and Genomics of Pulmonary Arterial Hypertension
2013
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
2006
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
2003
Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
2009
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Fibroblasts in cancer
2006 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
2015
Systemic sclerosis
2015
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
2016
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
2004
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
2019
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Peptides and the primary afferent nociceptor
1993
Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi?
2001
Collagen antibodies in rheumatoid arthritis. SIgnificance of antibodies to denatured collagen and their association with HLA‐DR4
1986
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
TRP ION CHANNELS AND TEMPERATURE SENSATION
2006 StandoutNobel
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
2017
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Physiology of Microglia
2011 Standout
Works of David H. Collier being referenced
Recombinant Human Relaxin in the Treatment of Scleroderma
2000
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
2002
Altered Immune Phenotype in Peripheral Blood Cells of Patients with Scleroderma‐Associated Pulmonary Hypertension
2010
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
1999
Kidney Transplantation for Systemic Sclerosis Improves Survival and may Modulate Disease Activity
2004
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
2017
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis
2016
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
1995
Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis.
1985
Recombinant Human Relaxin in the Treatment of Scleroderma
2000
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
2005
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis
2004
Anticollagen antibodies and immune response gene products in rheumatoid arthritis
1984